Bunge LimitedNYSE: BG
Consumer Staples · Agricultural Products & Services
$124.51
-2.01%
Vol: 857K
Research Digest
Friday, May 1, 2026
Bunge raises 2026 EPS guidance to $9.00-$9.50 after strong Q1 processing and refining segment performance
Bunge Global reported Q1 2026 adjusted EPS of $1.83 versus $1.81 in Q1 2025, with adjusted Total EBIT rising 55% to $561 million. The company raised full-year 2026 adjusted EPS outlook to $9.00-$9.50 (from $7.50-$8.00) citing strong Q1 performance and forward curve signals. Soybean Processing EBIT jumped 56% to $377M and Softseed Processing surged 138% to $195M, benefiting from Viterra acquisition capacity. Zacks upgraded BG to Strong Buy, with analyst consensus showing average rating of "Strong Buy" and 12-month target of $132.29.
Previous Market Intelligence
13 daysApr 30Bunge Global raises 2026 EPS guidance to $9.00-$9.50 on strong Q1 processing and refining outperformance (April 29)Positive▶
Bunge Global reported Q1 2026 adjusted EPS of $1.83 (beat vs $0.87 consensus) despite GAAP EPS of $0.35 due to lower one-time items. The company significantly raised full-year 2026 adjusted EPS guidance to $9.00-$9.50 from $7.50-$8.00, citing strong Q1 results and favorable margin environment. Adjusted EBIT surged 55% to $561M YoY, driven by Soybean Processing (+56% to $377M) and Softseed Processing (+138% to $195M) benefiting from expanded Viterra acquisition capacity. Revenue of $21.9B missed analyst estimates of $23.1B, but processing margins exceeded expectations.
Apr 29Bunge Global Q1 2026: $21.9B revenue (+87.8% YoY), EPS $0.35 down from $1.48 YoY, but raised FY2026 guidance to $9.25 at midpoint.Positive▶
Bunge Global reported Q1 2026 revenue of $21.86 billion, up 87.8% year-over-year (reflecting Viterra acquisition and stronger trading volumes) but missing Wall Street expectations of $23.113 billion. Non-GAAP EPS of $1.83 beat consensus of 87 cents. GAAP EPS declined to $0.35 from $1.48 due to higher SG&A expenses, increased interest expense, and a $94 million FX loss. Management raised full-year adjusted EPS guidance to $9.25 at midpoint (+19.4%), driven by strong Soybean and Refining segments. Analyst consensus is 'Strong Buy' with 12-month target of $132.29.
Apr 16Bunge Global expanded Accounts Receivable Securitization Program from $1.5B to $2B integrating Viterra, raising price targets JPMorgan to $130.Positive▶
Bunge Global expanded its Accounts Receivable Securitization Program from $1.5 billion to $2 billion, integrating newly merged Viterra Limited to support working capital and financing flexibility. The company will announce Q1 2026 results on April 29, 2026 prior to market opening, with management participating in a fireside chat at BMO Global Farm to Market Conference on May 13, 2026. Bunge successfully priced $1.2 billion aggregate principal in public offering and completed business combination with Viterra creating new opportunities across supply chains. The stock shows strong momentum with 15.34% increase over the past quarter and new dividend of $0.70 per share, with analyst price targets raised by JPMorgan to $130 from $117 and UBS to $145 from $108. Wall Street consensus is Strong Buy with 7 analysts and 12-month target of $132.29.
Apr 15Bunge Global expands accounts receivable securitization program to $2B, integrating Viterra acquisition.Positive▶
Finacity expanded Bunge Global's Accounts Receivable Securitization Program from $1.5B to $2B on April 13, incorporating the recently merged Viterra Limited. Multiple analysts raised price targets: JPMorgan to $130, UBS to $145, Barclays to $135. The company will report Q1 2026 results on April 29. Strong analyst consensus: Strong Buy with average target of $132.29.
Apr 14Bunge raises 2030 EPS target to $15+ from $13 baseline; $3B buyback and Viterra integration progressing.Mixed▶
Bunge updated financial framework raising 2030 EPS target to at least $15, backed by completed Viterra acquisition integration and IFF soy protein business closure March 2. Authorized $3B share repurchase program. Q1 2026 results April 29. Spruce Point Capital issued strong sell opinion on March 25.
Apr 13Barclays raised price target to $145; Q1 earnings April 29 with improved outlook; stock jumped 20% this week on cooking oil tariff developments.Positive▶
Bunge Global received analyst upgrade from Barclays with price target raised to $145 from $135, maintaining Overweight rating. Q1 2026 earnings will be announced April 29. Board proposes $2.88 annual dividend. Stock jumped 20% this week on cooking oil tariff developments.
Apr 10Bunge Global closes IFF protein acquisition; raises EPS mid-cycle baselinePositive▶
Closed IFF soy protein acquisition. $3B share repurchase program. EPS mid-cycle baseline raised to ~$13, targeting $15+ by 2030.
Apr 9Bunge Global hits 52-week high on strong earnings and debt offering.Positive▶
Bunge Global SA announced $1.2B debt offering for refinancing, buybacks, and capex (March 17). Hit 52-week high $131.93 on earnings beat and positive FY2026 guidance. 2025 revenue $70.33B (+32.4%) with strong agribusiness performance. Q1 2026 earnings April 29. Stock up 20% this week on tariff tailwinds. 7 analysts rate "Strong Buy" with $132.29 target.
Apr 8Bunge Global rises 1.42% after-hours following Viterra acquisition completion and analyst upgrades.Positive▶
Bunge completed Viterra acquisition March 17. JPMorgan raised PT to $134. Stock $128.72, +$1.42 after-hours. Q1 earnings April 29.
Apr 7$1.2B Debt Offering Fuels Strategic Returns and Tariff MomentumMixed▶
Bunge Global announced $1.2B senior unsecured notes offering in March, proceeds for debt repayment, share buybacks, capex, working capital. Stock up 20% amid tariff headlines vs China. Q1 earnings April 29. Dividend $0.70. Avg analyst PT $132.29 (Strong Buy). Analyst concerns about long-term valuation persist.
Apr 6Bunge completed Viterra acquisition; analyst upgrades on strong momentum and $1.2B capital raise.Positive▶
Bunge Global completed Viterra Limited acquisition in March 2026, raising $1.2B via senior notes in mid-March. Stock jumped ~20% week due to tariff volatility bullishness on cooking oil. Morgan Stanley upgraded from Equalweight to Overweight with raised price target. Company achieved 15.34% quarterly increase with new $0.70/share dividend (ex-date Feb 17, 2026). Strong Buy consensus from 7 analysts, $132.29 target (3.09% upside). Q1 2026 results announced April 29, 2026. Viterra acquisition creates new supply chain opportunities and positions company for greater stakeholder value.
Apr 3Bunge Q1 earnings April 29; Spruce Point report warns of 55%-80% downside despite company's $15 EPS 2030 target and Viterra integration.Mixed▶
Bunge Global SA will announce Q1 2026 results on April 29. The company held Investor Day on March 10, updating EPS mid-cycle baseline to ~$13. Spruce Point Capital released a Strong Sell report warning of 55%-80% downside. JPMorgan raised price target to $134 from $130. Recent completion of Viterra acquisition.
Apr 2Bunge Global surges on strong investor day and $3B buyback announcementPositive▶
Bunge Global surged 36.41% year-to-date and 70.06% over the past year on strong momentum from the Viterra acquisition integration and biofuels mandates tailwinds. At its 2026 Investor Day, Bunge raised its EPS mid-cycle baseline to $13 and targets growth to at least $15 by 2030, while announcing a $3 billion share repurchase program and commitment to return minimum 50% discretionary cash flow through dividends and buybacks. The company closed the acquisition of IFF's soy protein concentrate and lecithin business on March 2, 2026. JPMorgan raised its price target to $134 from $130 maintaining Overweight. Street consensus sits at $132.10 with 9 Buy ratings versus 1 Hold.
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| ADMARCHER | $74.98 | +0.58% | +1.6% | 15.3x | 0.64 | $35.9B |
| BGBUNGE | $124.51 | -2.01% | -1.1% | 12.3x | — | $24.6B |
| WMTWALMART | $131.84 | -0.07% | +4.0% | 40.2x | 0.66 | $1.05T |
| COSTCOSTCO | $1,012.70 | -0.18% | -0.4% | 45.1x | 0.98 | $450.1B |
| PGPROCTER | $147.58 | +0.33% | +3.0% | 20.7x | 0.40 | $342.5B |
| KOCOCA | $78.69 | -0.10% | +2.0% | 22.7x | 0.36 | $338.9B |
Key Fundamentals
RSI (14-Day)
52-Week Range
Moving Averages
Price above both MAs — bullish structure.